Conversa Health is a Health Care startup founded in 2014 and based in the United States. The company specializes in automated virtual health at scale, offering a platform that utilizes proprietary patient profiling and health signals engine along with an extensive library of evidence-based automated Conversational Care™ pathways. This allows healthcare organizations to effectively and efficiently risk stratify and remotely manage patients across the care continuum, aiming to develop meaningful relationships and drive better health outcomes. The latest milestone for Conversa Health was a $8.00M Series B investment on 19 January 2021, with notable investors including EPIC Ventures, StartUp Health, Builders VC, Alumni Ventures Blockchain Fund, Genesis Merchant Capital, Northwell Health, P5 Health Ventures, UH Ventures, J-Ventures, and Nassau Street Ventures. With a focus on virtual care and triage, Conversa Health stands at the forefront of innovation in addressing the evolving needs of the healthcare industry, especially pertinent in the context of remotely managing patients, risk stratification, and driving improved health outcomes. Joining forces with Amwell, the company continues to showcase potential to disrupt and improve the health tech sphere.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series B | $8.00M | 10 | Nassau Street Ventures, Alumni Ventures | 19 Jan 2021 |
Venture Round | $300.00K | 1 | Alumni Ventures | 17 Jun 2020 |
Series B | $12.00M | 7 | Nassau Street Ventures, Alumni Ventures | 11 Jun 2020 |
Series A | $9.00M | 3 | Healthgrades | 17 May 2017 |
Series A | Unknown | 1 | Jim Ellsworth | 30 Aug 2016 |
No recent news or press coverage available for Conversa Health.